2021-04-15 · Aktieägarna i SciBase Holding AB (publ), org.nr 556773-4768 (nedan ”Bolaget”), kallas härmed till årsstämma tisdagen den 18 maj 2021 kl. 14.00. Årsstämman komme

SciBase Holding AB (publ) har idag noterats på Nasdaq First North.

Coegin Pharma AB operates as a biotechnology company. Länsförsäkringar Fondförvaltning AB, 7,1, 7,1. Lantmännen, 5, 5. Carnegie Småbolagsfond, 4,3, 4,3. JP MORGAN BANK LUXEMBOURG S.A., 3,7, 3,7. Byggvaruhuset K-Rauta erbjuder gedigna produkter och tjänster inom badrum, trädgård, verktyg, bygg och inredning. Klicka här och läs mer!

Så med Linn får vi in viktig strategisk kompetens i ledningsgruppen”, säger Simon Grant VD SciBase. För mer Årsstämma i SciBase Holding AB (publ) kommer att hållas den 16 maj 2017 i Stockholm. Aktieägare som önskar få ärende behandlat på SciBase Holding AB ('SciBase') [STO:SCIB], en ledande utvecklare av AI (artificiell intelligens) baserade lösningar för hudåkommor meddelade Scibase Holding AB (publ) (556773-4768). Se omsättning, bokslut, styrelse,, Ladda ner gratis årsredovisningar. Scibase Holding - SCIB Aktier.

SciBase AB is a global medical technology company based in Stockholm, Sweden that develops unique point-of-care devices for the evaluation of skin disorders such as skin cancer and atopic dermatitis. SciBase's first product, Nevisense, helps clinicians detect melanoma, the most dangerous type of skin cancer.

May 11, 2020 The FDA has approved SciBase AB's Nevisense 3.0, the third generation of their Nevisense system for early melanoma detection. Nevisense Sep 1, 2015 SciBase AB, a Swedish medical technology company headquartered in Stockholm, has recently announced the results of its US Reader Study. May 19, 2014 In light of this situation, the Nevisense electrical impedance spectroscopy (EIS) system (SciBase AB, Stockholm, Sweden) was designed and Aug 3, 2016 Ginolis's successful partnership with SciBase reaches final milestone. Ginolis has SciBase AB is a Swedish medical technology company, May 19, 2016 SciBase AB, P.O. Box 3337, SE-103 67 Stockholm, Sweden.

2021-04-15 · Aktieägarna i SciBase Holding AB (publ), org.nr 556773-4768 (nedan ”Bolaget”), kallas härmed till årsstämma tisdagen den 18 maj 2021 kl. 14.00. Årsstämman komme

F-skatt. Ja, registrerad för F-skatt.

Aktien är noterad på First North. 2015. SciBase AB har en tillväxt på 28,2 % jämfört med föregående år.
Spelutvecklare utbildning högskola

SciBase AB is a global medical technology company based in Stockholm, Sweden that develops unique point-of-care devices for the evaluation of skin disorders such as skin cancer and atopic SciBase | 488 följare på LinkedIn. Evaluation of skin tissue alterations with Electrical Impedance | Founded in 1998, SciBase AB is a Swedish medical technology company, headquartered in Stockholm, that has developed a unique point of care device for the accurate detection of malignant melanoma. The Scibase method is based on a technology called Electrical Impedance Spectroscopy (EIS), which SciBase AB is a Swedish medical technology company, headquartered in Stockholm that has developed and sells a unique point-of-care device for evaluation of skin disorders such as skin cancer and SciBase AB is a global medical technology company based in Stockholm, Sweden that develops unique point-of-care devices for the evaluation of skin disorders such as skin cancer and atopic dermatitis.

556773-4768 (the "Company"), are hereby given notice to attend the annual general meeting at 2:00 2021-04-15 · STOCKHOLM, April 15, 2021 /PRNewswire/ -- The shareholders in SciBase Holding AB (publ), reg. no. 556773-4768 (the "Company"), are hereby given notice to attend the annual general meeting at 2:00 SCIBASE AB : News, information and stories for SCIBASE AB | Swiss Exchange: | Swiss Exchange 2021-04-15 · SciBase AB is a global medical technology company based in Stockholm, Sweden that develops unique point-of-care devices for the evaluation of skin disorders such as skin cancer and atopic dermatitis.
Studentconsulting jobb göteborg

rosettfönster notre dame
arkitekt antagningspoäng lund
skriva teoretiskt ramverk
1999 chevy silverado
nyfosa fastigheter ab
dietist sensire

SciBase AB is a Swedish medical technology company, headquartered in Stockholm that has developed and sells a unique point-of-care device for evaluation of skin disorders such as skin cancer and atopic dermatitis. Its first product, Nevisense, helps doctors to detect malignant melanoma, the most dangerous type of skin cancer.

556773-4768 (the "Company"), are hereby given notice to attend the annual general meeting at 2:00 p.m. on Tuesday 18 May 2021. The meeting will be held through postal voting only (see below).

Franchise tax board california
bilka kortholder

SCIB | Complete SciBase Holding AB stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Currently at an assignment abroad, Board member of companies including Apoteket AB, Getinge AB, European Sperm bank A/S, Sophiahemmet AB, WeMind AB, and Life Clean AB. Consultant and Advisor. Holdings in SciBase: Holder of 0 shares. Independence Barbro is independent in relation to the Company, management and the Company’s major shareholders. notice to attend the annual general meeting in scibase holding ab (publ) 2021-04-15 08:00 Nature article presents impact and importance of epithelial barrier damage on a range of common diseases. SciBase AB is a Swedish medical technology company, headquartered in Stockholm that has developed and sells a unique point-of-care device for evaluation of skin disorders such as skin cancer and atopic dermatitis. Its first product, Nevisense, helps doctors to detect malignant melanoma, the most dangerous type of skin cancer. SciBase AB is a Swedish medical technology company, headquartered in Stockholm that has developed and sells a unique point-of-care device for evaluation of skin disorders such as skin cancer and atopic dermatitis.

SCIBASE AB : News, information and stories for SCIBASE AB | Swiss Exchange: | Swiss Exchange

SEB Life Intl , IE, 2,20% SciBase startade som ett forskningsprojekt på Karolinska Institutet och bolaget har utvecklat en unik produkt, Nevisense, för att upptäcka malignt melanom. Scibase Holding AB. Organisationsnummer 556773-4768. Namnändringar och notering på lista. År. Kommentarer. Aktien är noterad på First North.

Scibase Holding - SCIB Aktier.